A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2011
03/23/2011	EP2298304A2 Carboline derivatives useful in the treatment of cancer
03/23/2011	EP2298303A1 Pharmaceutical combinations of hydrocodone and naltrexone
03/23/2011	EP2298302A1 Disposal systems of transdermal delivery devices to prevent misuse of the active agents contained therein
03/23/2011	EP2298301A2 Medicaments for increasing endogenous Erythropoietin (EPO)
03/23/2011	EP2298300A1 Compositions for inhibition of anglogenesis comprising thalidomide and aspirin
03/23/2011	EP2298299A2 O-methylated rapamycin derivatives for alleviation and inhibition of lymphoproliferative disorders
03/23/2011	EP2298298A2 Use of AT-1 receptor antagonist or AT-2 receptor modulator for treating diseases associated with an increase of AT-1 or AT-2 receptors
03/23/2011	EP2298297A1 Combination of an inhibitor of the If current of the sinus node and an inhibitor of the angiotensin converting enzyme
03/23/2011	EP2298296A1 Composition and method for treating cognitive impairments in down syndrome subjects
03/23/2011	EP2298295A1 Tumor necrosis factor inhibitors
03/23/2011	EP2298294A1 Oxybuprocaine-containing analgesic/antipruritic preparation for external application
03/23/2011	EP2298293A1 Lipase inhibitor
03/23/2011	EP2298292A2 Kinase inhibitors for treating cancers
03/23/2011	EP2298291A2 Kinase inhibitors for treating cancers
03/23/2011	EP2298288A1 Coated tablet formulation and method
03/23/2011	EP2298285A2 Method of making particles for use in a pharmaceutical composition
03/23/2011	EP2298284A2 Mucoadhesive pharmaceutical formulations
03/23/2011	EP2298283A2 Pharmaceutical formulations comprising cannabinoids
03/23/2011	EP2298281A1 Infusion and injection solution of Levodopa
03/23/2011	EP2298280A2 Gel comprising a combination of flurbiprofen and muscle relaxant
03/23/2011	EP2298279A2 Pharmaceutical compositions for inhalation
03/23/2011	EP2298275A1 Composition for external use
03/23/2011	EP2298090A1 Pharmaceutical or nutraceutical composition
03/23/2011	EP2298083A1 Delivery of functional compounds
03/23/2011	EP2298074A2 Facially amphiphilic polymers and oligomers, compositions thereof, and use thereof in methods of treating cancer
03/23/2011	EP2298071A1 Aqueous solution for the preservation of tissues and organs
03/23/2011	EP2297341A1 Methods and compositions for the treatment of huntington's disease
03/23/2011	EP2297323A1 5' triphosphate oligonucleotide with blunt end and uses thereof
03/23/2011	EP2297177A1 C-ring-substituted pregn-4-ene-21,17-carbolactone, and pharmaceutical preparations comprising the latter
03/23/2011	EP2297176A1 Novel nucleic acid transfer system
03/23/2011	EP2297167A1 Selenophene and selenazole carboxylic acid derivatives
03/23/2011	EP2297166A1 Substituted n-imidazo[2,1-b]thiazole-5-sulfonamide derivatives as 5-ht6 ligands
03/23/2011	EP2297164A1 Pyrazolospiroketone acetyl-coa carboxylase inhibitors
03/23/2011	EP2297163A1 Pyrazolospiroketone acetyl-c0a carboxylase inhibitors
03/23/2011	EP2297162A1 Compounds
03/23/2011	EP2297159A2 Substituted quinazolines
03/23/2011	EP2297158A1 Substituted quinazolines as blood platelet lowering agents
03/23/2011	EP2297157A1 2h- pyrimido ý2, 1-b¨quinaz0lin-2-0ne derivatives and their use as platelet anti-aggregative agents
03/23/2011	EP2297156A1 Substituted quinazolines and their uses for myeoloprolific and thrombotic diseases
03/23/2011	EP2297155A2 Method for producing bicyclic guanidines by use of a cyclic urea
03/23/2011	EP2297154A1 1- (7-(hexahydropyrrolo [3, 4-c]pyrrol-2 (1h) -yl) quin0lin-4-yl) -3- (pyrazin-2-yl) urea derivatives and related compounds as glycogen synthase kinase 3 (gsk-3)
03/23/2011	EP2297153A1 Limk2 inhibitors, compositions comprising them, and methods of their use
03/23/2011	EP2297152A1 Anhydrous crystal form of orvepitant maleate
03/23/2011	EP2297151A1 Inhibitors of protein kinases
03/23/2011	EP2297150A1 Substituted quinazolines as blood platelet lowering agents
03/23/2011	EP2297148A1 Novel derivatives of (bridged piperazinyl)-1-alcanone and use thereof as p75 inhibitors
03/23/2011	EP2297147A1 Azabicyclic compounds, preparation thereof and use of same as drugs, especially beta-lactamase inhibitors
03/23/2011	EP2297146A1 Substituted quinazolines
03/23/2011	EP2297145A2 Polymorphs of 5-(3-(ethylsulfonyl)phenyl)-3,8-dimethyl-n- (1-methylpiperidin-4-yl)-9h-pyrido[2, 3-b]indole-7-carboxamide and methods of use therefor
03/23/2011	EP2297144A1 Imidazopyridine and related analogs as sirtuin modulators
03/23/2011	EP2297143A1 Substituted aminothiazole prodrugs of compounds with anti-hcv activity
03/23/2011	EP2297142A1 Novel substituted pyridin-2-ones and pyridazin-3-ones
03/23/2011	EP2297141A1 Antiviral salts
03/23/2011	EP2297140A1 Novel 1,2,4 oxadiazole compounds and methods of use thereof
03/23/2011	EP2297139A1 Compounds
03/23/2011	EP2297138A1 Processes for the preparation of crystalline forms of sunitinib malate
03/23/2011	EP2297137A1 Novel heteroaryl carboxamide derivatives
03/23/2011	EP2297133A1 1, 2 disubstituted heterocyclic compounds
03/23/2011	EP2297131A2 Di-substituted phenyl compounds as phosphodiesterase 10 inhibitors
03/23/2011	EP2297129A1 Substituted cyclopropyl compounds, compositions containing such compounds and methods of treatment
03/23/2011	EP2297128A1 Inhibitors of ikk- serine-threonine protein kinase
03/23/2011	EP2297127A1 Chromenone derivatives useful for the treatment of neurodegenerative diseases
03/23/2011	EP2297121A2 Stabilization processes of cation radicals of phenothiazinic compounds, cosmeceutical formulations and methods for skin diseases and disturbances prevention
03/23/2011	EP2297120A1 Aminodihydrothiazine derivatives as bace inhibitors for the treatment of alzheimer's disease
03/23/2011	EP2297118A1 N- (1, 1, 1, 3, 3, 3-hexafluoro-2-hydroxypropan-2-yl) benzyl-n' -arylcarbonylpiperaz ine derivatives
03/23/2011	EP2297117A1 Bicyclic heterocycle derivatives and use thereof as gpr119 modulators
03/23/2011	EP2297116A1 Substituted quinazolines
03/23/2011	EP2297115A2 Quinazoline derivatives
03/23/2011	EP2297113A1 Dual-acting antihypertensive agents
03/23/2011	EP2297112A1 Pyrazole compounds as ccr1 antagonists
03/23/2011	EP2297110A1 Indane derivatives as ampa receptor modulators
03/23/2011	EP2297107A1 Ý4-(1-amino-ethyl) -cyclohexyl¨-methyl-amine and ý6-(1-amino-ethyl) -tetrahydro- pyran-3-yl¨-methyl-amine derivatives as antibacterials
03/23/2011	EP2297106A1 Phenoxypyridinylamide derivatives and their use in the treatment of pde4 mediated disease states
03/23/2011	EP2297105A1 Substituted amides, method of making, and use as btk inhibitors
03/23/2011	EP2297104A1 2-alkoxy-substituted dicyanopyridines and use thereof
03/23/2011	EP2297103A1 Hydroxyphenylsulfonamides as antiapoptotic bcl inhibitors
03/23/2011	EP2297102A1 Heteroaromatic monoamides as orexinin receptor antagonists
03/23/2011	EP2297100A1 Tetrahydrocyclopentaýb¨indole androgen receptor modulators
03/23/2011	EP2297099A1 3-cyanoalkyl- and 3-hydroxyalkylindoles and use thereof
03/23/2011	EP2297098A1 Pyrrolidine derivatives as nk2 receptor antagonists
03/23/2011	EP2297097A2 Compounds and compositions useful for the treatment of malaria
03/23/2011	EP2297092A1 Polymorphic and amorphous forms of lacosamide and amorphous compositions
03/23/2011	EP2297088A2 New compounds with activity that protects against the action of toxins and viruses in intracellular action mode
03/23/2011	EP2297087A2 Solid states of o-desmethylvenlaf axine salts
03/23/2011	EP2297085A2 Substituted arylcyclopentenes as therapeutic agents
03/23/2011	EP2297075A1 Dihydro-iso-ca-4 and analogues: potent cytotoxics, inhibitors of tubulin polymerization
03/23/2011	EP2296757A2 Inhibitors of the shiga toxins trafficking through the retrograde pathway
03/23/2011	EP2296748A1 Ketotifen transdermal drug delivery systems and methods for treating ophthalmic disease
03/23/2011	EP2296709A2 Modified release niacin formulations
03/23/2011	EP2296708A2 Polymeric carrier
03/23/2011	EP2296706A2 Photochemical internalisation of kinase inhibitors
03/23/2011	EP2296679A1 Abrogating proinflammatory cytokine production during oncolytic reovirus therapy
03/23/2011	EP2296678A1 Modulating interstitial pressure and oncolytic viral delivery and distribution
03/23/2011	EP2296670A1 Glycosaminoglycan oral use and compositions
03/23/2011	EP2296669A1 Targeted oligonucleotide compositions for modifying gene expression
03/23/2011	EP2296668A1 Compositions for the treatment of hair loss
03/23/2011	EP2296667A2 Silicone composition
03/23/2011	EP2296666A1 Use of fts for the treatment of myocardial ischemia/reperfusion injury
03/23/2011	EP2296665A2 Pharmaceutical composition for the treatment of premature ejaculation
03/23/2011	EP2296664A1 An inhibitor of anti-apoptotic proteins

1 ... 1824 1825 1826 1827 1828 1829 1830 1831 1832 1833 1834 1835 1836 1837 1838 1839 1840 1841 1842 1843 1844 ... 7860